Abrazo Arrowhead campus announced it is now offering Aquablation, a new therapy using waterjet ablation for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
BPH, or an enlarged prostate, is a non-cancerous condition where the prostate has grown to be larger than normal.
Nearly half of men between the ages 51 to 60 have BPH, and the incidence increases every decade of life. If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones and incontinence.
Surgical treatments for BPH may require men to consider trade-offs between symptom relief and side effects, according to Dr. Roscoe Nelson, a urologist on the medical staff at Abrazo Arrowhead Campus.
Aquablation therapy is a different type of treatment for BPH, Nelson explained. It’s an advanced, minimally invasive treatment that uses the power of water delivered with robotic precision to provide best-in-class and long-lasting symptom relief with low rates of irreversible complications, regardless of prostate size or shape.
“We are proud to be among the first in the community to offer a solution for men with BPH that provides relief without compromise,” said Abrazo Arrowhead Campus CEO Stephen Garner. “It is exciting to bring this new minimally invasive surgical technique to our community to improve the quality of care we provide.”
Aquablation therapy is performed by the AquaBeam Robotic System, the first FDA-cleared, surgical robot utilizing automated tissue resection or the treatment of lower urinary tract symptoms due to BPH. It combines real-time, multi-dimensional imaging, automated robotic technology, and heat-free waterjet ablation technology for targeted, controlled, and immediate removal of prostate tissue.
Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy and prostate size, Nelson said. In clinical studies, the therapy has shown to provide symptom relief with low rates of irreversible complications.
For more information about potential side effects and risks associated with Aquablation therapy, speak with a urologist who performs this procedure.
The therapy is the first FDA-cleared, surgical robot utilizing automated tissue resection for the treatment of lower urinary tract symptoms due to BPH.
For more information about Abrazo Arrowhead Campus, visit AbrazoHealth.com.
No comments on this item Please log in to comment by clicking here